Home > National Drug Code (NDC) > Triamterene and Hydrochlorothiazide Capsules

Triamterene and Hydrochlorothiazide Capsules - 51079-935-20 - (Triamterene and Hydrochlorothiazide Capsules)

Alphabetical Index


Drug Information of Triamterene and Hydrochlorothiazide Capsules

Product NDC: 51079-935
Proprietary Name: Triamterene and Hydrochlorothiazide Capsules
Non Proprietary Name: Triamterene and Hydrochlorothiazide Capsules
Active Ingredient(s): 25; 37.5    mg/1; mg/1 & nbsp;   Triamterene and Hydrochlorothiazide Capsules
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Triamterene and Hydrochlorothiazide Capsules

Product NDC: 51079-935
Labeler Name: UDL Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA074701
Marketing Category: ANDA
Start Marketing Date: 20110520

Package Information of Triamterene and Hydrochlorothiazide Capsules

Package NDC: 51079-935-20
Package Description: 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-935-20) > 1 CAPSULE in 1 BLISTER PACK (51079-935-01)

NDC Information of Triamterene and Hydrochlorothiazide Capsules

NDC Code 51079-935-20
Proprietary Name Triamterene and Hydrochlorothiazide Capsules
Package Description 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-935-20) > 1 CAPSULE in 1 BLISTER PACK (51079-935-01)
Product NDC 51079-935
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Triamterene and Hydrochlorothiazide Capsules
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20110520
Marketing Category Name ANDA
Labeler Name UDL Laboratories, Inc.
Substance Name HYDROCHLOROTHIAZIDE; TRIAMTERENE
Strength Number 25; 37.5
Strength Unit mg/1; mg/1
Pharmaceutical Classes Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC]

Complete Information of Triamterene and Hydrochlorothiazide Capsules


General Information